289 related articles for article (PubMed ID: 37062002)
21. POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLC.
Baine MK; Febres-Aldana CA; Chang JC; Jungbluth AA; Sethi S; Antonescu CR; Travis WD; Hsieh MS; Roh MS; Homer RJ; Ladanyi M; Egger JV; Lai WV; Rudin CM; Rekhtman N
J Thorac Oncol; 2022 Sep; 17(9):1109-1121. PubMed ID: 35760287
[TBL] [Abstract][Full Text] [Related]
22. Genetic profiling-based prognostic prediction of patients with advanced small-cell lung cancer in large scale analysis.
Udagawa H; Umemura S; Murakami I; Mimaki S; Makinoshima H; Ishii G; Miyoshi T; Kirita K; Matsumoto S; Yoh K; Niho S; Tsuchihara K; Goto K
Lung Cancer; 2018 Dec; 126():182-188. PubMed ID: 30527185
[TBL] [Abstract][Full Text] [Related]
23. Comparative study of the genomic landscape and tumor microenvironment among large cell carcinoma of the lung, large cell neuroendocrine of the lung, and small cell lung cancer.
Li F; Yang Y; Xu Y; Li K; Song L; Xue Y; Dong D
Medicine (Baltimore); 2023 Jan; 102(4):e32781. PubMed ID: 36705391
[TBL] [Abstract][Full Text] [Related]
24. Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung.
Miyoshi T; Umemura S; Matsumura Y; Mimaki S; Tada S; Makinoshima H; Ishii G; Udagawa H; Matsumoto S; Yoh K; Niho S; Ohmatsu H; Aokage K; Hishida T; Yoshida J; Nagai K; Goto K; Tsuboi M; Tsuchihara K
Clin Cancer Res; 2017 Feb; 23(3):757-765. PubMed ID: 27507618
[TBL] [Abstract][Full Text] [Related]
25. Differential regulation and synthetic lethality of exclusive RB1 and CDKN2A mutations in lung cancer.
Kim N; Song M; Kim S; Seo Y; Kim Y; Yoon S
Int J Oncol; 2016 Jan; 48(1):367-75. PubMed ID: 26647789
[TBL] [Abstract][Full Text] [Related]
26. Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.
Zhang JT; Li Y; Yan LX; Zhu ZF; Dong XR; Chu Q; Wu L; Zhang HM; Xu CW; Lin G; Yu ZY; Hu J; Zhu B; Wang HJ; Yang F; Song ZB; Han ZB; Li MX; Lin J; Wu YL; Wang JL; Zhong WZ
Lung Cancer; 2020 Jan; 139():118-123. PubMed ID: 31775086
[TBL] [Abstract][Full Text] [Related]
27. Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D.
Simbolo M; Mafficini A; Sikora KO; Fassan M; Barbi S; Corbo V; Mastracci L; Rusev B; Grillo F; Vicentini C; Ferrara R; Pilotto S; Davini F; Pelosi G; Lawlor RT; Chilosi M; Tortora G; Bria E; Fontanini G; Volante M; Scarpa A
J Pathol; 2017 Mar; 241(4):488-500. PubMed ID: 27873319
[TBL] [Abstract][Full Text] [Related]
28. Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients.
Fathi Z; Mousavi SAJ; Roudi R; Ghazi F
PLoS One; 2018; 13(7):e0200633. PubMed ID: 30048458
[TBL] [Abstract][Full Text] [Related]
29. Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer.
Bhateja P; Chiu M; Wildey G; Lipka MB; Fu P; Yang MCL; Ardeshir-Larijani F; Sharma N; Dowlati A
Cancer Med; 2019 Apr; 8(4):1459-1466. PubMed ID: 30773851
[TBL] [Abstract][Full Text] [Related]
30. Comparison of genomic landscapes of large cell neuroendocrine carcinoma, small cell lung carcinoma, and large cell carcinoma.
Zhou Z; Zhu L; Niu X; Shen S; Zhao Y; Zhang J; Ye J; Han-Zhang H; Liu J; Liu C; Lu S
Thorac Cancer; 2019 Apr; 10(4):839-847. PubMed ID: 30793508
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs.
Du L; Schageman JJ; Irnov ; Girard L; Hammond SM; Minna JD; Gazdar AF; Pertsemlidis A
J Exp Clin Cancer Res; 2010 Jun; 29(1):75. PubMed ID: 20624269
[TBL] [Abstract][Full Text] [Related]
32. Cell plasticity in patients with NSCLC: The controversial origins of transformed SCLC.
Liang X; Lin A; Wang Q; Zhang J; Luo P
Biomed Pharmacother; 2022 May; 149():112909. PubMed ID: 36068773
[TBL] [Abstract][Full Text] [Related]
33. Progress in the knowledge on the transformation of lung adenocarcinoma to small-cell lung cancer.
Wang A; Han C; Zhao H; Zheng Z; Ye X; Shan R
J Cancer Res Ther; 2023 Feb; 19(1):14-19. PubMed ID: 37006037
[TBL] [Abstract][Full Text] [Related]
34. Exploring imaging features of molecular subtypes of large cell neuroendocrine carcinoma (LCNEC).
Hermans BCM; Sanduleanu S; Derks JL; Woodruff H; Hillen LM; Casale R; Hoesein FM; de Jong E; Berge DMHJT; Speel EJM; Lambin P; Gietema HA; Dingemans AC
Lung Cancer; 2020 Oct; 148():94-99. PubMed ID: 32858338
[TBL] [Abstract][Full Text] [Related]
35. Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer.
Udyavar AR; Hoeksema MD; Clark JE; Zou Y; Tang Z; Li Z; Li M; Chen H; Statnikov A; Shyr Y; Liebler DC; Field J; Eisenberg R; Estrada L; Massion PP; Quaranta V
BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S1. PubMed ID: 24564859
[TBL] [Abstract][Full Text] [Related]
36. Current knowledge of small cell lung cancer transformation from non-small cell lung cancer.
Giaccone G; He Y
Semin Cancer Biol; 2023 Sep; 94():1-10. PubMed ID: 37244438
[TBL] [Abstract][Full Text] [Related]
37. Genomic based analyses reveal unique mutational profiling and identify prognostic biomarker for overall survival in Chinese small-cell lung cancer.
Wang Y; Han X; Wang X; Sheng W; Chen Z; Shu W; Han J; Zhao S; Dai Y; Wang K; Shi W; Yang Z
Jpn J Clin Oncol; 2019 Dec; 49(12):1143-1150. PubMed ID: 31612912
[TBL] [Abstract][Full Text] [Related]
38. Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin.
Oser MG; Niederst MJ; Sequist LV; Engelman JA
Lancet Oncol; 2015 Apr; 16(4):e165-72. PubMed ID: 25846096
[TBL] [Abstract][Full Text] [Related]
39. Case report: TP53 and RB1 loss may facilitate the transformation from lung adenocarcinoma to small cell lung cancer by expressing neuroendocrine markers.
Li J; Wei B; Feng J; Wu X; Chang Y; Wang Y; Yang X; Zhang H; Han S; Zhang C; Zheng J; Groen HJM; van den Berg A; Ma J; Li H; Guo Y
Front Endocrinol (Lausanne); 2022; 13():1006480. PubMed ID: 36583000
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]